SJS Investment Consulting’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
Other funds holding PACB
SJS Investment Consulting's PACB Position: Q3 2026 in Review
SJS Investment Consulting sold out of Pacific Biosciences (PACB) in Q3 2026, closing a stake of 1,144 shares — an estimated $1.92K sold.
SJS Investment Consulting first reported a position in PACB in Q1 2023 and held it in 7 quarters. The position peaked at $1.92K in Q2 2026. 205 funds tracked by Wall St. Rank hold PACB as of Q3 2026.
- SJS Investment Consulting reported no remaining Pacific Biosciences position as of Q3 2026 after selling out during the quarter.
- SJS Investment Consulting sold 1,144 Pacific Biosciences shares in Q3 2026, an estimated $1.92K.
- SJS Investment Consulting first reported a position in Pacific Biosciences in Q1 2023 and held it in 7 quarters.
- SJS Investment Consulting's Pacific Biosciences position peaked at $1.92K in Q2 2026.
- 205 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2026.
Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.